You are on page 1of 36

This data can be easily copy pasted into a Microsoft Excel sheet

Sun Pharmaceutical
Previous Years
Industries

Standalone ------------------Balance Sheetin Rs. Cr. ------------------Mar '12


Mar '11
Mar '10
Mar '09
Mar '08
Total Liabilities8,148.91
6,731.06
5,747.47
5,175.02
4,310.14
Net Current Assets
2,839.53
2,107.19
963.11
1,705.22
1,803.10
Total Assets 8,148.91
6,731.06
5,747.47
5,175.02
4,310.14

Mar '07
Mar '06
Mar '05
Mar '04
Mar '03
Total Liabilities3,517.64
3,210.76
2,920.10
1,171.82
Net Current Assets
1,838.95
1,864.15
1,447.77
219.63
Total Assets 3,517.64
3,210.76
2,920.10
1,171.82

696.22
311.88
696.22

Sun Pharmaceutical
Previous Years
Industries

Standalone ------------------Profit & Loss in


account
Rs. Cr. ------------------Mar '12
Mar '11
Mar '10
Mar '09
Mar '08
Sales Turnover 4,080.49
1,985.78
1,891.16
2,833.65
2,427.35
Reported Net Profit
1,927.98
1,383.80
898.65
1,265.29
1,014.04
Earning Per Share18.62
(Rs)
13.36
43.39
61.09
48.96

Standalone ------------------Profit & Loss in


account
Rs. Cr. ------------------Mar '07
Mar '06
Mar '05
Mar '04
Mar '03
Sales Turnover 1,722.13
1,353.01
1,056.01
897.59
864.65
Reported Net Profit
628.93
461.29
305.71
240.6
231.41
Earning Per Share32.52
(Rs)
24.83
16.48
25.84
24.83

atrix Laboratories
Previous Years
Standalone ------------------Balance Sheetin Rs. Cr. ------------------Mar '10
Mar '09
Mar '08
Mar '07
Mar '06
Total Liabilities1,764.09
1,525.40
1,131.30
1,205.55
1,025.22
Net Current Assets
595.71
532.81
308.83
235.92
263.96
Miscellaneous Expenses
0
0
0
0
0
Total Assets 1,764.09
1,525.42
1,131.31
1,205.55
1,025.21

Mar '05
Mar '04
Mar '03
Mar '02
Mar '01
Total Liabilities 670.07
385.69
232.24
40.48
Net Current Assets
139.46
115.62
77.77
11.32
Miscellaneous Expenses
0
0
0
0
Total Assets
670.05
385.7
232.24
40.5

27.06
13.27
1.49
27.06

atrix Laboratories
Previous Years
Standalone ------------------Profit & Loss in
account
Rs. Cr. ------------------Mar '10
Mar '09
Mar '08
Mar '07
Mar '06
Sales Turnover 1,894.30
1,504.41
973.82
774.81
694.58
Reported Net Profit
213.83
188.95
-298.36
99.61
182.38
Earning Per Share13.68
(Rs)
12.22
-19.3
6.46
11.87
Equity Dividend (%)
0
0
0
0
60
Book Value (Rs)
73.7
56.23
43.98
63.5
56.6

Mar '05
Mar '04
Mar '03
Mar '02
Mar '01
Sales Turnover 672.42
557.41
416.93
103.89
Reported Net Profit
130.27
124.61
75.05
5.61
Earning Per Share (Rs)
8.7
101.23
77.13
7.81
Equity Dividend (%) 60
110
100
10
Book Value (Rs) 41.68
144.4
101.72
29.94

67.88
4.2
10.51
0
30.8

Dr Reddys Laboratories
Previous Years
Standalone ------------------Balance Sheetin Rs. Cr. ------------------Mar '13
Mar '12
Mar '11
Mar '10
Mar '09
Total Liabilities9,372.50
8,251.20
7,465.00
6,477.80
5,899.40
Net Current Assets
4,183.10
3,239.10
2,741.60
1,764.10
2,412.30
Miscellaneous Expenses
0
0
0
0
0
Total Assets 9,372.50
8,251.20
7,465.00
6,477.80
5,899.40

Next Years Previous Years


Dr Reddys Laboratories
Standalone ------------------Balance Sheetin Rs. Cr. ------------------Mar '08
Mar '07
Mar '06
Mar '05
Mar '04
Mar '03
Total Liabilities5,274.12
4,703.26
3,186.01
2,347.31
2,105.24 Total Liabilities
Net Current Assets
1,960.26
2,773.62
1,599.92
1,366.20
929.84 Net Current Assets
Miscellaneous Expenses
0
0
0
0
0 Miscellaneous Expenses
Total Assets 5,274.09
4,703.26
3,186.02
2,347.33
2,105.24 Total Assets

Mar '02
Mar '01
Mar '00
1,835.68
1,471.81
928.69
1,151.71
1,011.89
424.14
0
0
94.56
1,835.69
1,471.79
928.69

609.83
223.4
53.89
609.84

Dr Reddys Laboratories
Previous Years
Sales Turnover 8,505.80
6,780.20
Reported Net Profit
1,265.50
912.4
Earning Per Share74.51
(Rs)
53.81

5,285.80
893.4
52.78

4,469.60
846.1
50.11

4,080.40
560.9
33.29

Sales Turnover 3,428.40


Reported Net Profit
475.22
Earning Per Share28.26
(Rs)

3,872.92
1,176.86
70.09

2,101.97
211.12
27.53

1,625.56
65.46
8.55

1,740.20 Sales Turnover


283.2 Reported Net Profit
37.01 Earning Per Share (Rs)

1,618.56
392.09
51.24

1,572.84
459.65
60.07

991.24
144.47
45.73

493.02
60.32
22.77

Ranbaxy Laboratories
Previous Years
Standalone ------------------Profit & Loss in
account
Rs. Cr. ------------------Dec '12
Dec '11
Dec '10
Dec '09
Dec '08
Sales Turnover 6,331.46
7,709.17
5,687.33
4,797.49
4,676.21
Reported Net Profit
-162.34 -3,052.05
1,148.73
571.98 -1,044.80
Earning Per Share-3.84
(Rs)
-72.32
27.28
13.61
-24.85

Next Years Previous Years


Ranbaxy Laboratories
Standalone ------------------Profit & Loss in
account
Rs. Cr. ------------------Dec '07
Dec '06
Dec '05
Dec '04
Dec '03
Sales Turnover 4,344.39
4,218.98
3,727.05
3,865.86
3,888.97
Reported Net Profit
617.72
380.54
212.04
527.52
794.78
Earning Per Share16.56
(Rs)
10.21
5.69
28.38
42.84

anbaxy Laboratories
Previous Years
Standalone ------------------Balance Sheetin Rs. Cr. ------------------Dec '12
Dec '11
Dec '10
Dec '09
Dec '08
Total Liabilities6,685.69
6,258.36
9,393.12
7,482.98
7,442.14
Net Current Assets
1,401.38
752.95
3,546.38
1,640.98
1,938.67
Miscellaneous Expenses
0
0
0
0
0
Total Assets 6,685.68
6,258.36
9,393.11
7,482.99
7,442.15

Dec '07
Dec '06
Dec '05
Dec '04
Dec '03
Total Liabilities6,041.43
5,528.61
3,407.10
2,645.37
2,356.02
Net Current Assets
1,006.93
1,112.75
1,011.52
824.58
1,227.74
Miscellaneous Expenses
0
0
0
0
0
Total Assets 6,041.42
5,528.61
3,407.11
2,645.39
2,356.03

Orchid Chemicals
Previousand
Years
Pharmaceuticals

Standalone ------------------Balance Sheetin Rs. Cr. ------------------Mar '12


Mar '11
Mar '10
Mar '09
Mar '08
Total Liabilities2,858.34
2,979.20
2,626.75
3,183.38
2,641.53
Mar '12
Mar '11
Mar '10
Mar '09
Mar '08
12 mths
Net Current Assets
427.67
Miscellaneous Expenses
0
Total Assets 2,858.34

12 mths
642.61
0
2,979.20

12 mths
571.34
0
2,626.77

12 mths
648.9
0
3,183.40

12 mths
497.59
0
2,641.55

Mar '07
Mar '06
Mar '05
Mar '04
Mar '03
Total Liabilities2,133.18
1,813.28
1,458.15
1,178.89
999.37
Mar '07
Mar '06
Mar '05
Mar '04
Mar '03
12 mths
Net Current Assets
484.58
Miscellaneous Expenses
0
Total Assets 2,133.16

12 mths
555.97
0
1,813.28

12 mths
347.79
0
1,458.17

12 mths
276.14
0
1,178.89

12 mths
201.97
0
999.38

Orchid Chemicals
Previousand
Years
Pharmaceuticals

Standalone ------------------Profit & Loss in


account
Rs. Cr. ------------------Sales Turnover 1,750.62
1,680.80
1,240.78
1,203.21
Reported Net Profit
103.11
159.48
331.34
-52.17
Earning Per Share14.64
(Rs)
22.64
47.04
-7.41

1,250.18
184.54
28.02

Sales Turnover 906.54


Reported Net Profit
96.63
Earning Per Share14.68
(Rs)

853.91
82.9
12.83

653.05
31.01
9.09

712.34
31.03
9.58

540.56
19.54
6.03

Wockhardt Previous Years


Standalone ------------------Balance Sheetin Rs. Cr. ------------------Mar '12
Mar '11
Mar '10
Dec '08
Dec '07
Total Liabilities1,845.38
2,568.60
2,549.77
2,497.91
1,834.84
Mar '12
Mar '11
Mar '10
Dec '08
Dec '07
Net Current Assets
-145.3
717.65
1,056.02
1,115.12
621.69
Miscellaneous Expenses
0
0
0
0
0
Total Assets 1,845.38
2,568.61
2,549.76
2,497.91
1,834.83

ec '06
Dec '05
Dec '04
Dec '03
Dec '02
Total Liabilities1,664.06
1,614.90
1,437.01
774.32
407.93
Dec '06
Dec '05
Dec '04
Dec '03
Dec '02
Net Current Assets
802.91
833.84
801.13
267.63
93.17
Miscellaneous Expenses
0
0
0
0
0
Total Assets 1,664.06
1,614.88
1,437.01
774.31
407.93

This data can be easily copy pasted into a Microsoft Excel sheet
Wockhardt Previous Years
Standalone ------------------Profit & Loss in
account
Rs. Cr. ------------------Mar '12
Mar '11
Mar '10
Dec '08
Dec '07
Sales Turnover 2,566.32
1,758.91
1,872.98
1,512.47
1,252.02
Reported Net Profit184
-132.06
-794.21
-348.76
213.88
Earning Per Share16.79
(Rs)
-12.07
-72.57
-31.87
19.54

Dec '06
Dec '05
Dec '04
Dec '03
Dec '02
Sales Turnover 1,158.59
1,009.20
881.54
765.79
Reported Net Profit
213.55
238.47
207.78
133.36
Earning Per Share19.51
(Rs)
21.82
19.06
36.74

741.64
108.84
29.79

Fresenius Kabi
Previous
Oncology
Years
Standalone ------------------Balance Sheetin Rs. Cr. ------------------Mar '13
Mar '12
Mar '11
Mar '10
Mar '09
Total Liabilities 813.34
739.91
874.29
761.2
654.33
Net Current Assets
298.5
296.57
391
378.93
326.16
Miscellaneous Expenses
0
0.12
0.13
0
0.46
Total Assets
813.34
739.9
874.27
761.2
654.34

Mar '08
Mar '07
Mar '06
Mar '05
Mar '04
Total Liabilities
694
480.92
362.03
272.11
212
Net Current Assets
298.73
183.68
123.2
69.85
67.66
Miscellaneous Expenses
14.2
2.64
6.54
4.03
0
Total Assets
693.99
480.93
362.02
272.11
212.01

This data can be easily copy pasted into a Microsoft Excel sheet
Aurobindo Pharma
Previous Years
Standalone ------------------Balance Sheetin Rs. Cr. ------------------Mar '13
Mar '12
Mar '11
Mar '10
Mar '09
Total Liabilities5,714.06
4,935.12
4,887.33
3,859.14
3,435.51
Net Current Assets
2,827.83
2,115.82
2,461.43
1,935.09
1,998.94
Miscellaneous Expenses
0
0
0
0
0
Total Assets 5,714.06
4,935.12
4,887.33
3,859.14
3,435.51

Mar '08
Mar '07
Mar '06
Mar '05
Mar '04
Total Liabilities2,976.25
2,905.66
2,110.67
1,652.71
1,409.76
Net Current Assets
1,734.44
1,807.31
1,072.64
730.16
676.27
Miscellaneous Expenses
0
0
0
0
0
Total Assets 2,976.25
2,905.66
2,110.67
1,652.71
1,409.76

Aurobindo Pharma
Previous Years
Standalone ------------------Profit & Loss in
account
Rs. Cr. ------------------Mar '13
Mar '12
Mar '11
Mar '10
Mar '09
Income
Sales Turnover 5,569.50
4,378.73
4,229.99
3,319.60
2,885.25
Reported Net Profit
495.99
-42.61
593.8
525.76
128.54
Earning Per Share17.03
(Rs)
-1.46
20.4
94.34
23.91

Next Years Previous Years


Aurobindo Pharma
Standalone ------------------Profit & Loss in
account
Rs. Cr. ------------------Mar '08
Mar '07
Mar '06
Mar '05
Mar '04
Income
Sales Turnover 2,351.12
1,979.76
1,472.36
1,159.87
1,341.37
Reported Net Profit
290.78
229.08
69.38
35.08
127.02
Earning Per Share54.08
(Rs)
42.94
13.02
6.91
25.02

Aurobindo Pharma
Standalone Profit & Loss
Income
account
Mar '12
Total Liabilities
Net Current Miscellaneous
Assets
Total
Expenses
AssetsSales Turnover
Aurobindo Pharma
4,935.12
2,115.82
0
4,935.12
4,378.73
Wockhardt
1,845.38
-145.3
0
1,845.38
2,566.32
Orchid Chemicals
2,858.34
and Pharmaceuticals
427.67
0
2,858.34
1,750.62
Ranbaxy Laboratories
6,685.69
1,401.38
0
6,685.68
6,331.46
Dr Reddys Laboratories
8,251.20
3,239.10
0
8,251.20
6,780.20
Matrix Labs 1,764.09
595.71
0
1,764.09
1,894.30
Sun Pharma 8,148.91
2,839.53
0
8,148.91
4,080.49

Reported Net
Earning
Profit Per Share (Rs)
-42.61
-1.46
184
16.79
103.11
14.64
-162.34
-3.84
912.4
53.81
213.83
13.68
1,927.98
18.62

Standalone Profit & Loss account


Previous Years------------------
Mar
in '12
Rs. Cr. ------------------Wockhardt Standalone Balance Sheet
Previous Years------------------
Mar
in '12
Rs. Cr. -------------------

Ranbaxy Laboratories
Previous Years

Standalone Balance Sheet


Previous Years------------------
Mar
in '12
Rs. Cr. -------------------

Orchid Chemicals
Standalone
and Pharmaceuticals
Sales
Profit Turnover
& Loss account
Previous Years------------------
in Rs. Cr. -------------------

Standalone Balance Sheet


Mar '12

Sales Turnover
Reported Net
Earning
Profit Per Share (Rs)

Total Liabilities
Mar '12

Net Current Miscellaneous


Assets
Total
Expenses
Assets

Standalone Profit & Loss


Sales
account
Turnover
Reported Net
Earning
Profit Per Share (Rs)
------------------Dec
in Rs.
'12 Cr. -------------------

Total Liabilities
Mar '12

Net Current Miscellaneous


Assets
Expenses
12 mths

Reported Net
Earning
Profit Per Share (Rs)
---------- in Rs. Cr. -------------------

Total Liabilities
Net Current Miscellaneous
Assets
Total
Expenses
Assets

Total Liabilities
Net Current Miscellaneous
Assets
Total
Expenses
Assets

Total Assets